BACKGROUND: local excision for early rectal cancer has gained widespread interest. Currently available imaging modalities have low sensitivity to detect locoregional disease, which may result in understaging and a high risk of recurrence after local excision.
t he gold-standard surgical approach for low rectal cancer involves low anterior resection or abdominoperineal resection with total mesorectal excision. however, recently published population-based studies have shown that the treatment of early rectal cancers by various local excision (le) techniques have more than doubled over the last 2 decades.
1,2 the national Cancer Database registry shows that ≤62% of patients with stage t1 rectal cancer are being treated by le across the united states. 2 this increase in the use of transanal excision techniques for early stage rectal cancer has likely stemmed from the desire to save the sphincter complex, placing a higher priority on maintaining bowel continuity than oncologic clearance. the practice parameters of the american society of Colon and Rectal surgeons state that, "local excision is an appropriate treatment modality for carefully
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selected t1 rectal cancer without high risk features." 3 the risk of lymph node metastasis in stage i rectal cancers has been reported to range from 11% to 32%. 4 hence, patient selection should depend on the absence of lymph nodal spread on preoperative imaging, as well as lymphovascular invasion on pathology.
identification of nodal disease by various modalities has been suboptimal. the accuracy of endorectal ultrasound (eRus) and/or mRi is 60% to 80% at its best, with an inability to find lymph nodes <5 mm in size, which have the potential to harbor metastasis. [5] [6] [7] [8] this explains the oncologic inferiority of le, with local recurrence as the most common pattern of failure, ranging from 20% to 30% as reported by several authors.
9-14 therefore, the use of le for treatment of early rectal cancer has to be weighed against high local recurrence rates. When these patients develop local recurrence, what surgical options are available for cure, and what are the prognosis and long-term survival? this study aimed to determine the morbidity, mortality, risks of rerecurrence, and long-term survival in select patients after multimodal salvage treatment of locally recurrent rectal cancer after le.
PATIENTS AND METHODS
our study protocol was approved by the institutional review board at the mayo Clinic. all of the patients who had a transanal excision for early rectal cancer at our center between 1997 and 2013 and subsequently developed a local and/or regional recurrence that required radical resection with multimodal therapy were included in the study. the study cohort also included patients who underwent transanal excision at other facilities and were referred to us thereafter for the management of locally recurrent rectal cancer. Patient(s) who underwent definitive radical surgery within 6 weeks of the index le based on unfavorable pathologic features of the resected specimen were excluded from the study cohort. there were a total of 9 such patients; 6 had a t2 lesion, whereas the remaining 3 patients had t1 cancer with lymphovascular invasion; in all of the cases, radical surgery was recommended. other exclusion criteria included patients with synchronous distant metastasis (3 patients) and or a neuroendocrine tumor of the rectum (1 patient). Patients who underwent le of rectal cancer due to an inability to tolerate a radical resection because of medical comorbidities were also excluded from the study group.
Clinicopathologic variables and treatment pathways for the study patients were extracted from the medical charts. Patterns of recurrence after le were reviewed. a multidisciplinary team managed the course of salvage treatment for locally recurrent rectal cancers. We studied the operative findings, final pathology, and need for intraoperative radiation during salvage resection. any negative margin (>1 mm) was considered to be an R0 resection. operative morbidity, outcomes, and mortality of the radical surgery were analyzed. After radical resection of local recurrence, recommended surveillance protocol included an examination every 3 to 6 months with Cea level during the first 2 years, colonoscopy 1 year after salvage surgery, and then every 3 years. selective use of eRus, pelvic mRi, or positron emission tomography for surveillance was based on the discretion of the treating physician. the primary outcome of the study was overall and disease-specific survival after salvage multimodal therapy. any rerecurrence after salvage surgery was investigated for patterns of recurrence, treatment offered, and outcomes.
all of the continuous variables were expressed as mean ± sD. nominal variables were compared with χ 2 tests. a p value of <0.05 in a 2-tailed analysis was considered significant. Survival curves were plotted using the Kaplanmeier method.
RESULTS
twenty-seven patients were identified; 9 were men. all of the patients had undergone full-thickness le of early rectal cancer. eight patients initially had an endoscopic polypectomy that detected a focus of invasive cancer and then proceeded to a full-thickness transanal excision of the rectal neoplasm. the average distance from the anal verge was 6 cm (range, 2-10 cm). Mean tumor size was 2.0 cm (range, 0.8-4.0 cm). the postoperative t stage after le was as follows: tis (n = 2), tx (n = 2), t1 (n = 16), and t2 (n = 7; table 1). Data on lymphovascular invasion were unavailable in 20 patients, that is, all of the patients who had their initial surgery at outside hospitals. in the 7 patients who underwent primary le at our institution, none had lymphovascular invasion. although 93% of patients underwent surveillance after le, data on the frequency and adequacy of surveillance were not available and could not be included.
the majority of recurrences observed in the study were luminal (23 patients). three patients had locoregional recurrences involving adjacent pelvic organs, including the urinary bladder (n = 1), uterus (n = 1), and vagina (n = 1). mesorectal nodal recurrences were identified in 6 patients. Preoperative staging of recurrent rectal cancer was performed using eRus (n = 14), mRi (n = 5), or both (n = 3). in the remaining 5 patients, t stage was determined by pathology after full-thickness transanal excision of the suspected focus of recurrence. in 70% (n = 19) of the patients, recurrence presented as locally advanced disease (t3 or t4).
the mean age of patients (n = 27) at the time of salvage surgery for locally recurrent rectal cancer was 66 ± 12 years. Radical resection of the local recurrence with negative margins was feasible in 93% (n = 25) of this highly selected patient cohort. the details about salvage multi-modal therapy are listed in table 2. sphincter preservation was possible in 9 patients (33%). early and late postoperative complications from salvage surgery are shown in table 3. thirty-day perioperative mortality was nil. median follow-up after salvage surgery was 3 years (range, 3 months to 13 years). Figure 1 shows the Kaplan-Meier survival curves for overall and disease-free survival in the study cohort. sites of rerecurrences are shown in table 4.
DISCUSSION
in this single-institution case series, we report the outcomes of 27 highly selected patients who underwent multimodal salvage surgery for local recurrence of rectal cancer after previous transanal excision of early rectal cancer. an R0 resection rate of 93% in this highly selected cohort of patients was associated with a 5-year recurrence-free survival rate of 47% (95% Ci, 25%-68%) and a 5-year overall survival rate of 50% (95% Ci, 30%-74%). the majority of rerecurrences were distant metastases. although salvage resection was feasible for treatment of this highly select group of patients, the long-term survival results were disappointing. survival rates in our cohort look particularly grim when compared with published rates of 92% to 97% disease-free survival at 5 years after upfront radical resection for primary early rectal cancer.
1 this highlights the fact that patients should be well informed of the risks of recurrence and associated salvage when choosing le for early rectal cancer.
the findings of this study add to the growing body of literature suggesting that salvage resection for recurrence after le is associated with only modest success. 15 an R0 resection rate of 94%, requiring a multivisceral resection in 63%. You et al 15 performed extended resections in 38%, with an R0 resection rate of 80%. morbidity was high in all studies (44%-50%), but the majority of complications did not have long-term consequences. interestingly, sphincter salvage was possible in 20%-33% of patients at the time of salvage surgery across the 3 cohorts, suggesting that sphincter preservation would likely have been possible at the time of le. in the study by You et al, 15 after a median follow-up of 33 months, actuarial 5-year survival was 53%, 3 year rerecurrence-free survival was 43%, and 5-year overall survival was 63%. three-year disease-free survival in our study was similar at 47%.
our work here presents a very unique and highly selected cohort of patients who underwent le for early rectal cancer, developed local recurrence, and had multimodal therapy for salvage at our institution. the strength of our data is in the fact that it included only patients with early rectal cancer (t0-t2) who subsequently underwent salvage for isolated locoregional recurrence. Previous publications on this topic included patients treated by le for t3 tumors as well. there are many limitations in this work. it is retrospective in nature, and the cohort includes a small number of highly selected patients treated at a tertiary care referral center. therefore, data on survival outcomes from the study must be weighed against an inherent referral and selection bias. the data presented here also do not allow for evaluation of the success or failure of le as a surgical approach for early rectal cancers. in addition, the important pathologic variables of the index cancer (presence or absence of lymphovascular or perineural invasion, etc) were not available in all of the patients who had the le performed at an outside facility, nor was the exact surveillance protocol known for all of the patients.
this study highlights the feasibility of multimodal salvage therapy in highly selected patients with locally recurrent rectal cancer after le. surgical salvage is possible at a cost of relatively high postoperative morbidity and disappointingly low long-term survival, especially considering the early stage of the index rectal cancer. Recent data based on a randomized clinical trial offering either le or total mesorectal excision after neoadjuvant therapy in t2n0 low rectal cancers with good histologic features has provided evidence that upfront multimodal treatment of early rectal cancer reduces the local recurrence rate after le. 17 Preliminary data from the american College of Surgeons Oncology Group Z6041 trial has reported a high pathologic response rate to neoadjuvant chemoradiation, but long-term oncologic outcomes of this trial are pending publication. 18 until those results are known, providers offering le as an alternative to proctectomy for early rectal cancer are obligated to counsel the patients of not only the published increased risk of local recurrence and the need for stringent surveillance after le but also the moderate success of salvage resection in the case of local recurrence. future prospective studies are needed to better identify patients at the highest risk of local failure. Time to recurrence after radical resection, y Figure 1 . Disease-free survival and overall survival after radical surgery. Disease-free survival at 1 year = 95%; 3 years = 47%; 5 years = 47%. Overall survival at 1 year = 100%; 3 years = 75%; 5 years = 50%. 
